Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study — Fredrik Schjesvold (2024) | RDL Network
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study
Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, María‐Victoria Mateos, Martin Kaiser, Roman Hájek, Shibao Feng, Kim Cocks, Jaqueline Buchanan, Katja Weisel
Pieter Sonneveld, Paul G. Richardson, Heinz Ludwig, Meletios A Dimopoulos, Fredrik Schjesvold, Roman Hájek, Haifaa Abdulhaq, Marcus Thuresson, Stefan Norin, Nicolaas A. Bakker, María‐Victoria Mateos
Torben Plesner, Meletios A Dimopoulos, Albert Oriol, Jesús F. San Miguel, Nizar J. Bahlis, Neil Rabin, Kenshi Suzuki, Sung‐Soo Yoon, Dina Ben‐Yehuda, Gordon Cook, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud, Katharine S. Gries
Fredrik Schjesvold, Meletios A Dimopoulos, Sosana Delimpasi, Paweł Robak, Daniel Coriu, Wojciech Legieć, Luděk Pour, Ivan Špıčka, Tamás Masszi, Vadim Doronin, Jiří Minařík, Galina Salogub, Yulia Alexeeva, Antonio Lazzaro, Vladimír Maisnar, Gábor Mikala, Stefan Norin, Marcus Thuresson, A. Bergan, Jakob Obermüller, Roman Hájek, María‐Victoria Mateos,
Discussion(0)
No comments yet. Be the first to comment.